Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for isotretinoin submitted by Upsher-Smith Laboratories, LLC, indicating an approved change related to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)